COTQF News 0.1790 Critical Outcome Tec (COTQF)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Critical Outcome Tec (COTQF) 0.1790 $COTQF

Critical Outcome Technologies Applies for Orphan Drug Designation for COTI-2 Treatment of Ovarian Cancer
Marketwire Canada - Fri Apr 04, 8:00AM CDT
Critical Outcome Technologies Inc. ("COTI" or the "Company" (TSX VENTURE:COT), the bioinformatics and accelerated drug discovery company, announced today it has submitted an Orphan Drug Application to the U.S. Food and Drug Administration (FDA) for its lead cancer drug candidate, COTI-2, for the treatment of ovarian cancer.

Critical Outcome Technologies Reports Third Quarter Results
Marketwire - Fri Mar 14, 8:02AM CDT
Critical Outcome Technologies Inc. (TSX VENTURE: COT) ("COTI" or the "Company", the bioinformatics and accelerated drug discovery company, reported its financial and operating results today for the three and nine month periods ended January 31, 2014.

Critical Outcome Technologies Inc. Announces Warrant Term Amendment
Marketwire - Fri Mar 07, 3:31PM CST
Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that it has received acceptance from the TSX Venture Exchange ("TSXV" to extend the expiry term of 1,575,500 common share purchase warrants ("Warrants" issued as part of its private placement in April and May 2010 representing the third amendment made for these warrants.

Critical Outcome Technologies Identifies Experienced Partner for Clinical Development of COTI-2
Marketwire - Wed Feb 26, 8:31AM CST
Critical Outcome Technologies Inc. ("COTI" or the "Company" (TSX VENTURE: COT), the bioinformatics and accelerated drug discovery company, is pleased to announce that it has signed a non-binding letter of intent ("LOI" to form a joint venture with Portage Biotech Inc. ("Portage", a British Virgin Island incorporated public company, listed and traded on the Canadian Securities Exchange ("PTB.U", and on NASDAQ and the OTC ("PTGEF" to fund and direct the Phase 1 development of the Company's clinical oncology candidate, COTI-2.

Critical Outcome Technologies Completes Private Placement
Marketwire - Thu Feb 06, 8:14AM CST
Critical Outcome Technologies Inc. (TSX VENTURE: COT) ("COTI" or the "Corporation", the bioinformatics and accelerated drug discovery company, announced today that it has completed an arm's length non-brokered private placement raising approximately $500,000 consisting of a non-convertible debenture (the "Debenture" in the amount of $400,000 and an equity placement of 769,230 units (the "Units" at a price of $0.13 per Unit for approximately $100,000.

New York Mortgage Trust Announces Tax Treatment of Common Stock Dividends for 2013
GlobeNewswire - Fri Jan 31, 3:01PM CST
New York Mortgage Trust, Inc. (Nasdaq:NYMT) ("NYMT" or the "Company" today announced the following tax treatment for dividends declared in 2013 on the Company's common stock.

Catlin Buys 22.5% Stake in Russian Re From AIG
Michael Buck - AMBest - Fri Jan 31, 2:42PM CST
A subsidiary of Catlin Group Ltd. has purchased a 22.5% stake in Russian Reinsurance Co. from American International Group.

Critical Outcome Technologies Reports Second Quarter Results
Marketwire - Wed Dec 18, 3:49PM CST
Critical Outcome Technologies Inc. (TSX VENTURE: COT) ("COTI" or the "Company" reported its financial and operating results today for the three and six month periods ended October 31, 2013.

Critical Outcome Technologies Awards Stock Options
Marketwire - Fri Dec 06, 3:05PM CST
Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT), the bioinformatics and accelerated drug discovery company, announced today that it awarded 971,168 stock options to directors and officers under the Company's Stock Option Plan. The options awarded to directors were made as a retainer for their service on the Board and its committees for the ensuing year. The options have a five year life with 25% vesting occurring at the end of each quarter from the date of grant. The exercise price is $0.18 and represents the closing price of the Company's common shares on December 4, 2013, the last trading day reported on the TSX Venture Exchange prior to the meeting date.

Critical Outcome Technologies Provides Business and Scientific Update at Annual General Meeting
Marketwire - Fri Dec 06, 7:47AM CST
Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT), the bioinformatics and accelerated drug discovery company, announced today that its President & Chief Executive Officer, Dr. Wayne Danter, provided a business and scientific developments update of the Company at its Annual General and Special Meeting (AGM) of Shareholders held on Thursday, December 5, 2013.

COTI-2, a P53 Dependent Treatment for Many Common Cancers, Receives Additional U.S. Patent Protection
Marketwire - Wed Nov 13, 8:03AM CST
Critical Outcome Technologies Inc. ("COTI" or the "Company" (TSX VENTURE: COT), the bioinformatics and accelerated drug discovery company, is pleased to announce that the United States ("U.S." Patent and Trademark Office has recently granted an additional patent for the Company's lead oncology asset, COTI-2. COTI-2 now has five U.S. patents granted, with several more pending.

Critical Outcome Technologies Announces Warrant Expiry Date Amendment
Marketwire - Tue Oct 29, 3:15PM CDT
Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that it is extending the expiry date of 12,500,000 common share purchase warrants (Warrants) issued as part of three tranches of a non-brokered private placement on March 25, April 7 and April 21, 2011 respectively. Each Warrant entitled its holder to purchase one common share of the Company at an exercise price of $0.30 per share for a period of 18 months from the date of issue.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVRx Lawsuit Puts a Hard Date on Investor Decisions

Updated Category News Views 0

One ugly filing after the bell can vaporize years of shareholder confidence, and CVRx just supplied the painful exhibit. On August 7, 2026, shares of CVRx fell $3.55, or 59.76%, to close at $2.39 after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That is not a routine bad quarter. It is the sort of disclosure...

Continue Reading
MTI Adds Aviation Veterans as Acorn Builds MRO Plan

Updated Category News Views 95

Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...

Continue Reading
Africa Tech Festival Puts Trust Ahead of AI Hype Cycle

Updated Category News Views 11

Fifteen thousand people can fill a convention centre, but they cannot magically deliver a package, fund a small business, or repair harm from a bad automated decision. That rather useful dose of reality ran through the final day of Africa Tech Festival 2026 in Cape Town. The 29th edition drew more than 15,000 delegates across three days, and the strongest message was not...

Continue Reading
Home Nursing Plans Need Clarity Before the Next Crisis

Updated Category News Views 61

A medication change scribbled on a loose sheet can become a very long night. That is the unglamorous truth behind the discussion from Michael and Marsha Reda of Aurora Home Care in Williamsville, New York: long-term home nursing care depends on a plan people can actually follow when the household is tired, worried, and juggling too much. Their perspective, featured by...

Continue Reading
Hope Charities Makes Care Funding Easier to Track Online

Updated Category News Views 72

A treatment bill can wreck a household long before a diagnosis does. That is the uncomfortable reality behind Hope Charities' new Access to Care website, a centralized resource meant to show people in the bleeding disorders community when diagnosis-specific charitable assistance funds are available. This is not flashy technology, nor should it be treated like some grand...

Continue Reading
GreenTree Faces Softer Rooms, Debt and NYSE Deadline

Updated Category News Views 18

A hotel operator can post positive earnings and still leave shareholders with a nasty headache, and GreenTree's third quarter is that kind of report. NYSE:GHG produced RMB243.0 million in revenue, down 22.2% from a year earlier, while net income slipped to RMB49.3 million from RMB59.0 million. This was not a one-line stumble. Room pricing, occupancy, franchise economics...

Continue Reading
New York Gala Puts $3 Million Behind EB Research Work

Updated Category News Views 0

Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...

Continue Reading
BBW Lawsuit Puts Guidance and Walmart Claims Under Lens

Updated Category News Views 65

A three-month slice of 2026 has landed Build-A-Bear in the sort of mess investors hate most: a securities complaint centered on whether management's upbeat messaging had already outrun the facts. The lawsuit targets purchases of BBW shares from May 28, 2026 through August 26, 2026, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and...

Continue Reading
SDG&E's 21-Year Reliability Run Has Real Investor Weight

Updated Category News Views 66

Seventy minutes without power in a year is the sort of number most people ignore until their refrigerator quits humming. For San Diego Gas & Electric customers, though, it is a meaningful operating result: roughly 70 minutes annually from unplanned outages, on average, over the past decade, alongside fewer than one sustained outage per customer each year. SDG&E has also...

Continue Reading
Midea’s SC26 Cooling Pitch Targets AI Build Delays

Updated Category News Views 49

Heat is the uninvited partner in every AI build, and Midea is making a sensible argument that nobody gets paid for racks sitting idle while piping crews wrestle with a complicated cooling plant. At SC26 in Chicago, held November 17 through 19, the company made its North American debut for a modular prefabricated AI data-center cooling setup built around a magnetic coolant...

Continue Reading

Top 5 Most Recently Viewed Articles

GENFIT Achieves Milestone with EU Approval for Iqirvo®

Updated Category News Views 121

GENFIT Secures EU Approval for Iqirvo® GENFIT, a leading biopharmaceutical firm, has proudly announced that it received conditional approval from the European Commission for its medication Iqirvo® (elafibranor) at an 80mg dosage. This remarkable treatment is tailored for adults dealing with Primary Biliary Cholangitis (PBC) and is intended to be used in conjunction with...

Continue Reading
Yellow Pages Limited Q3 2025: Financial Highlights and Future Outlook

Updated Category News Views 252

Overview of Yellow Pages Limited's Financial Performance Yellow Pages Limited (TSX: Y), a notable player in the Canadian digital media and marketing landscape, has recently announced its financial results for the third quarter of 2025. The company showcases solid profitability and remains committed to its growth strategies. During this quarter, Yellow Pages Limited...

Continue Reading
Prosus's Major Move: Acquiring Despegar for $1.7 Billion

Updated Category News Views 230

Prosus's Strategic Acquisition of Despegar Prosus (OTC: PROSF) NV, recognized as a leading global technology investor, has revealed its intention to acquire Despegar (NYSE: DESP), a prominent online travel agency in Latin America, for an impressive sum of $1.7 billion. Under the terms of this agreement, shareholders of Despegar will benefit from a payment of $19.50 per...

Continue Reading
Discover Roof AI: Revolutionizing Roof Visualization for All

Updated Category News Views 207

Introducing Roof AI: The Future of Roof Visualization Roof AI has emerged as an innovative solution, especially after the successful launches of Remodel AI and Paint AI. It's designed to bring a significant transformation in how homeowners, contractors, designers, and roofing manufacturers visualize roofs before making any decisions. Whether you're planning a roof...

Continue Reading
Associa Celebrates Employee Recognition in National Awards

Updated Category News Views 240

Associa's Remarkable Achievement in Workplace Recognition Associa, a leader in community association management, proudly shares its recognition as a 2024 winner of the prestigious Best and Brightest Companies to Work for in the Nation. This accolade marks an impressive sixth recognition for the company, a testament to its unwavering dedication to cultivating an innovative...

Continue Reading